tiprankstipranks
Trending News
More News >
Propanc Biopharma (PPCB)
NASDAQ:PPCB
US Market
Advertisement

Propanc Biopharma (PPCB) Income Statement

Compare
61 Followers

Propanc Biopharma Income Statement

Last quarter (Q3 2025), Propanc Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Propanc Biopharma's net income was $-54.07M. See Propanc Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -21.66K$ -17.76K$ -5.67K$ 0.00
Operating Expenses
$ 57.28M$ 1.51M$ 1.76M$ 1.99M$ 1.81M
Depreciation and Amortization
$ 0.00$ 21.66K$ 22.93K$ 1.99K$ 1.99K
EBITDA
$ -57.28M$ -1.26M$ -2.23M$ -2.14M$ -1.69M
Operating Income
$ -57.28M$ -1.54M$ -1.78M$ -1.99M$ -1.81M
Other Income/Expenses
$ -1.65M$ -414.00K$ -1.01M$ -722.00K$ -327.00K
Pretax Income
$ -58.92M$ -1.95M$ -2.79M$ -2.71M$ -2.14M
Net Income
$ -58.92M$ -1.82M$ -2.66M$ -2.66M$ -2.03M
Per Share Metrics
Basic EPS
$ -14.85$ -1.42K$ -31.27K$ -1.12M$ -800.00
Diluted EPS
$ -14.85$ -1.20K$ -31.27K$ -1.12M$ -800.00
Weighted Average Shares Outstanding
3.97M 1.42K 100.00 3.00 3.03K
Weighted Average Shares Outstanding (Diluted)
3.97M 1.42K 100.00 3.00 3.03K
Currency in USD

Propanc Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis